Analyst Research: Optimer Pharmaceuticals Inc (OPTR.OQ)
OPTR.OQ on NASDAQ Stock Exchange Global Select Market
12.48USD
1 Aug 2013
12.48USD
1 Aug 2013
Price Change (% chg)
$-0.03 (-0.24%)
$-0.03 (-0.24%)
Prev Close
$12.51
$12.51
Open
$12.64
$12.64
Day's High
$12.65
$12.65
Day's Low
$12.48
$12.48
Volume
558,582
558,582
Avg. Vol
327,918
327,918
52-wk High
$16.77
$16.77
52-wk Low
$8.66
$8.66
| Name | Age | Since | Current Position |
|---|---|---|---|
Henry McKinnell |
70 | 2013 | Chairman of the Board, Chief Executive Officer |
Stephen Webster |
51 | 2012 | Chief Financial Officer and Principal Financial and Accounting Officer |
Eric Sirota |
51 | 2013 | Chief Operating Officer |
Sherwood Gorbach |
77 | 2011 | Senior Vice President, Chief Scientific Officer |
Linda Amper |
55 | 2011 | Senior Vice President - Human Resources |
- Cubist to pay up to $1.6 billion for two antibiotics makers
- UPDATE 2-Cubist to pay up to $1.6 bln for two antibiotics makers
- Cubist to buy Trius Therapeutics, Optimer Pharma for up to $1.62 billion
- CORRECTED-Cubist to buy Trius Therapeutics, Optimer Pharma for up to $1.62 bln
- Cubist bid for Optimer before sale process began: sources

